[1] |
Chen WQ,Zheng RS,Peter D,et al.Cancer statistics in China,2015[J].CA:Cancer J Clin,2016,66(2):115-132.
|
[10] |
Fridlender ZG,Sun J,Mishalian I,et al.Transcriptomic analysis comparing tumor-associated neutrophils with granulocyt icmyeloid-derived suppress or cells and normal neutrophils[J].PLoS One,2012,7(2):e31524.
|
[11] |
史敬东,钟志强,李有国,等.结直肠癌初治患者外周血中性粒细胞与淋巴细胞比值临床病理特征的关系及其预后价值分析[J].癌症进展,2017,15(6):709-712.
|
[12] |
张丽,刘芳芳,付丽.肿瘤间质浸润淋巴细胞在乳腺癌中的意义及评价方法[J].中华病理学杂志,2016,45(4):282-284.
|
[13] |
Malietzis G,Giacometti M,Askari Aet al.A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery[J].An Surg,2014,260(2):287-292.
|
[14] |
Choi WJ,Cleghorn MC,Jiang H,et al.Preoperative neutrophil-to-lymphocyte ratio is a better prognostic serum biomarker than platelet-to-lymphocyte ratio in patients undergoing resection for nonmetastatic colorectal cancer[J].Ann Surg Oncol,2015,22(S3):603-613.
|
[15] |
陈卓,顾飞腾,朱建林,等.术前外周血中性粒细胞和淋巴细胞比值与结直肠癌术后病理的相关性分析[J].临床医药文献电子杂志,2017,4(82):16 193-16 195.
|
[16] |
庄肃非.中性粒细胞/淋巴细胞比值与结直肠癌临床病理特征关系的研究[D].银川:宁夏医科大学,2016.
|
[17] |
Shibutani M,Maeda K,Nagahara H,et al.The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer[J].World J Surg Oncol,2015,13:194.
|
[18] |
Balde AI,Fang S,He L,et al.Propensity score analysis of recurrence for neutrophil-to-lymphocyte ratio in colorectal cancer[J].J Surg Res,2017,219:244-252.
|
[19] |
Kishi Y,Kopetz S,Chun YS,et al.Blood neutrophil-tolymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy[J].Ann Surg Oncol,2009,16(3):614-622.
|
[20] |
Stotz M,Pichler M,Absenger G,et al.The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage Ⅲ colon cancer[J].Br J Cancer,2014,110(2):435-440.
|
[2] |
万德森.结直肠癌流行病学与预防[J].中国中西医结合外科杂志,2011,17(1):3-7.
|
[3] |
Pine JK,Morris E,Hutchins GG,et al.Systemic neutrophilto-lymphocyte ratio in colorectal cancer:the relationship to patientsurvival,tumour biology and local lymphocytic response to tumour[J].Br J Cancer,2015,113(2):204-211.
|
[4] |
Kesler CT,Liao S,Munn LL,et a l.Lymphatic vessels in health and disease[J].Wiley Interdiscip Rev Syst Biol Med,2013,5(1):111-124.
|
[5] |
Lee BS,Lee SH,Son JH,et al.Neutrophil-lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy[J].Cancer Immunol Immunother,2016,65(2):141-150.
|
[6] |
陈创奇,方乐堃,马晋平,等.结直肠癌2042 例临床病理特点及预后回归分析[J].中华医学杂志,2010,90(26):1804-1807.
|
[7] |
Balkwill F,Mantovani A.Inflammation and cancer:back to Virchow?[J].Lancet,2001,357(9255):539-545.
|
[8] |
王战波,王勇,阮翊.术前外周血中性粒细胞和淋巴细胞比值在结直肠癌预后中的意义[J].中华临床医师杂志(电子版),2016,10(6):785-789.
|
[9] |
江慧洪,王晖,李阿建,等.中性粒细胞/淋巴细胞比值对局部进展期结直肠癌患者预后的影响[J].中华胃肠外科杂志,2017,20(5):550-554.
|